Replies to post #142668 on Biotech Values

[mcbio]

I imagine its because the number of patients with greater than 50% expression levels was quite small or there was none in the control arm to compare against. Hard to know at this point. Data needs time to mature.

Thanks. Could well be one of those scenarios.